Rising Rupee Cuts Into Nicholas Piramal Revenues
This article was originally published in PharmAsia News
Executive Summary
NEW DELHI - Mumbai-based Nicholas Piramal has lowered its revenue forecast in the current financial year because of rapid gains by the rupee against the dollar and pledged to cut low-margin products from its portfolio to ensure net profit would meet target